Compare Mahindra Manulife Flexi Cap Fund vs ICICI Prudential Focused Equity Fund
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.05 | 1.69 |
NAV | ₹16.42 | ₹97.25 |
Fund Started | 30 Jul 2021 | 15 Apr 2009 |
Fund Size | ₹1596.73 Cr | ₹14568.53 Cr |
Exit Load | Exit load 1% if redeemed within 3 months. | Exit load of 1% if redeemed within 1 year |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.05
1.69
NAV
₹16.42
₹97.25
Fund Started
30 Jul 2021
15 Apr 2009
Fund Size
₹1596.73 Cr
₹14568.53 Cr
Exit Load
Exit load 1% if redeemed within 3 months.
Exit load of 1% if redeemed within 1 year
1 Year | 8.65% | 18.84% |
3 Year | 16.78% | 23.13% |
5 Year | - | 20.17% |
1 Year
8.65%
18.84%
3 Year
16.78%
23.13%
5 Year
-
20.17%
Equity | 98.71% | 97.46% |
Cash | 1.29% | 1.87% |
Equity
98.71%
97.46%
Cash
1.29%
1.87%
Top 10 Holdings |
|
|
Top 10 Holdings
HDFC Bank Ltd. | 7.87% |
ICICI Bank Ltd. | 7.38% |
Reliance Industries Ltd. | 5.53% |
Infosys Ltd. | 4.58% |
Axis Bank Ltd. | 3.59% |
Tata Consultancy Services Ltd. | 3.45% |
Larsen & Toubro Ltd. | 3.29% |
Bajaj Finance Ltd. | 3.27% |
State Bank of India | 2.66% |
Hindustan Unilever Ltd. | 2.56% |
ICICI Bank Ltd. | 7.60% |
HDFC Bank Ltd. | 5.57% |
Infosys Ltd. | 4.83% |
Axis Bank Ltd. | 4.58% |
Sun Pharmaceutical Industries Ltd. | 4.52% |
Godrej Consumer Products Ltd. | 3.92% |
Titan Company Ltd. | 3.90% |
NTPC Ltd. | 3.73% |
Info Edge (India) Ltd. | 3.71% |
Britannia Industries Ltd. | 3.70% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity and equity-related securities across market capitalization. | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. |
Launch Date | 30 Jul 2021 | 15 Apr 2009 |
Description
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity and equity-related securities across market capitalization.
The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap.
Launch Date
30 Jul 2021
15 Apr 2009